Self-assembly antimicrobial peptide for treatment of multidrug-resistant bacterial infection

J Nanobiotechnology. 2024 Oct 30;22(1):668. doi: 10.1186/s12951-024-02896-5.

Abstract

The wide-spreading of multidrug resistance poses a significant threat to human and animal health. Although antimicrobial peptides (AMPs) show great potential application, their instability has severely limited their clinical application. Here, self-assembled AMPs composed of multiple modules based on the principle of associating natural marine peptide N6 with ß-sheet-forming peptide were designed. It is noteworthy that one of the designed peptides, FFN could self-assemble into nanoparticles at 35.46 µM and achieve a dynamic transformation from nanoparticles to nanofibers in the presence of bacteria, resulting in a significant increase in stability in trypsin and tissues by 1.72-57.5 times compared to that of N6. Additionally, FFN exhibits a broad spectrum of antibacterial activity against multidrug-resistant (MDR) gram-positive (G+) and gram-negative (G-) bacteria with Minimum inhibitory concentrations (MICs) as low as 2 µM by membrane destruction and complemented by nanofiber capture. In vivo mouse mastitis infection model further confirmed the therapeutic potential and promising biosafety of the self-assembled peptide FFN, which can effectively alleviate mastitis caused by MDR Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus), and eliminate pathogenic bacteria. In conclusion, the design of peptide-based nanomaterials presents a novel approach for the delivery and clinical translation of AMPs, promoting their application in medicine and animal husbandry.

Keywords: Antimicrobial peptide N6; Bacterial-capture; Bovine mastitis; Nanoparticles and nanofibers; Self-assembly; Stability.

MeSH terms

  • Animals
  • Anti-Bacterial Agents* / chemistry
  • Anti-Bacterial Agents* / pharmacology
  • Anti-Bacterial Agents* / therapeutic use
  • Antimicrobial Peptides* / chemistry
  • Antimicrobial Peptides* / pharmacology
  • Antimicrobial Peptides* / therapeutic use
  • Drug Resistance, Multiple, Bacterial* / drug effects
  • Escherichia coli* / drug effects
  • Female
  • Humans
  • Mastitis / drug therapy
  • Mastitis / microbiology
  • Mice
  • Mice, Inbred BALB C
  • Microbial Sensitivity Tests*
  • Nanofibers / chemistry
  • Nanofibers / therapeutic use
  • Nanoparticles / chemistry
  • Staphylococcus aureus / drug effects

Substances

  • Anti-Bacterial Agents
  • Antimicrobial Peptides